Jinhai Medical Technology (HKG:2225) received the results of the inquiry of the Securities and Futures Commission into the company's shareholding on
The results showed that 27 shareholders held 41.26% of the issued shares of the company and Chen Guobao, the company's chairman, held 48.94% of issued shares as of Nov. 20.
The shareholdings mentioned above make up 90.20% of the issued shares of the company leaving only 9.80% for other shareholders, a Monday Hong Kong bourse filing said.
SFC further mentioned that the company's shares' closing price rose by 77.65% to HK$9.06 on Nov. 20 from HK$5.10 on Sept. 13. The shares closed at HK$8.50 on Friday, representing an increase of 66.67% from HK$5.10 on Sept. 13.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。